Your browser doesn't support javascript.
loading
Pretreatment with ibrutinib reduces cytokine secretion and limits the risk of obinutuzumab-induced infusion-related reactions in patients with CLL: analysis from the iLLUMINATE study.
Greil, Richard; Tedeschi, Alessandra; Moreno, Carol; Anz, Bertrand; Larratt, Loree; Simkovic, Martin; Gill, Devinder; Gribben, John G; Flinn, Ian W; Wang, Zhengyuan; Cheung, Leo W K; Nguyen, Aaron N; Zhou, Cathy; Styles, Lori; Demirkan, Fatih.
Afiliação
  • Greil R; IIIrd Medical Department Paracelsus Medical University, Salzburg Cancer Research Institute-CCCIT, Cancer Cluster Salzburg, Salzburg, Austria. r.greil@salk.at.
  • Tedeschi A; Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.
  • Moreno C; Department of Hematology, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Barcelona, Spain.
  • Anz B; Department of Medical Oncology, Tennessee Oncology, Chattanooga, TN, USA.
  • Larratt L; Department of Clinical Hematology, University of Alberta Hospital, Edmonton, Alberta, Canada.
  • Simkovic M; Department of Internal Medicine - Hematology, University Hospital and Medical School Hradec Králové, Hradec Králové, Czech Republic.
  • Gill D; Department of Clinical Hematology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
  • Gribben JG; Centre for Haemato-Oncology, Queen Mary University of London, Barts Cancer Institute, London, UK.
  • Flinn IW; Center for Blood Cancers, Medical Oncology, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN, USA.
  • Wang Z; Translational Medicine, Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA, USA.
  • Cheung LWK; Translational Medicine, Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA, USA.
  • Nguyen AN; Translational Medicine, Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA, USA.
  • Zhou C; Biostatistics, Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA, USA.
  • Styles L; Clinical Science, Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA, USA.
  • Demirkan F; Department of Hematology, Dokuz Eylül University, Izmir, Turkey.
Ann Hematol ; 100(7): 1733-1742, 2021 Jul.
Article em En | MEDLINE | ID: mdl-34018029
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piperidinas / Pré-Medicação / Adenina / Leucemia Linfocítica Crônica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica / Citocinas / Anticorpos Monoclonais Humanizados Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piperidinas / Pré-Medicação / Adenina / Leucemia Linfocítica Crônica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica / Citocinas / Anticorpos Monoclonais Humanizados Idioma: En Ano de publicação: 2021 Tipo de documento: Article